The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells
出版年份 2015 全文链接
标题
The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells
作者
关键词
-
出版物
LEUKEMIA
Volume 29, Issue 12, Pages 2296-2306
出版商
Springer Nature
发表日期
2015-08-11
DOI
10.1038/leu.2015.219
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells
- (2015) Chie Nishioka et al. PLoS One
- Limited Value of KAI1/CD82 Protein Expression as a Prognostic Marker in Human Gastric Cancer
- (2013) Maximilian Knoener et al. DISEASE MARKERS
- CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells
- (2013) Chie Nishioka et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers
- (2013) Teodora Karan-Djurasevic et al. MEDICAL ONCOLOGY
- Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia
- (2012) Hellinida Thomadaki et al. CLINICAL BIOCHEMISTRY
- Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells
- (2012) Christos K. Kontos et al. GENE
- CD34+/CD38−acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells
- (2012) Chie Nishioka et al. INTERNATIONAL JOURNAL OF CANCER
- Genomics of Acute Myeloid Leukemia: The Next Generation
- (2012) Laura Riva et al. Frontiers in Oncology
- What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator
- (2011) Alexander H. Stegh et al. CELL CYCLE
- Cooperation between both Wnt/ -catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion
- (2011) J. M. Perry et al. GENES & DEVELOPMENT
- Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells
- (2011) Chie Nishioka et al. LEUKEMIA RESEARCH
- The Novel Member of the BCL2 Gene Family, BCL2L12, Is Substantially Elevated in Chronic Lymphocytic Leukemia Patients, Supporting Its Value As a Significant Biomarker
- (2011) S. G. Papageorgiou et al. ONCOLOGIST
- Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor
- (2010) A. H. Stegh et al. GENES & DEVELOPMENT
- Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+/CD38− cells and sensitizes them to antileukemia agents
- (2010) Takayuki Ikezoe et al. INTERNATIONAL JOURNAL OF CANCER
- Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice
- (2010) Jean-Emmanuel Sarry et al. JOURNAL OF CLINICAL INVESTIGATION
- AZ960, a Novel Jak2 Inhibitor, Induces Growth Arrest and Apoptosis in Adult T-Cell Leukemia Cells
- (2010) J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer
- (2009) Dimitra Florou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer
- (2008) Christos K. Kontos et al. BIOLOGICAL CHEMISTRY
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Bcl2L12-mediated inhibition of effector caspase-3 and caspase-7 via distinct mechanisms in glioblastoma
- (2008) A. H. Stegh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started